Atopaxar

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAtopaxar
Drug Alias Name阿托帕沙atopaxarum阿托帕萨E-5555ER-172594-00
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-1 antagonists
TargetsProtease-activated receptor-1
Therapy Area/IndicationsCoronary Artery DiseaseAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai IncEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseAcute Coronary Syndrome

Other Information

ATC CodeN/A
Related LinksKEGG